These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22989751)

  • 1. Letter to the Editor on "Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro".
    Kapoor S
    Biochem Biophys Res Commun; 2012 Oct; 427(2):438. PubMed ID: 22989751
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro.
    Deb Majumdar I; Devanabanda A; Fox B; Schwartzman J; Cong H; Porco JA; Weber HC
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):397-402. PubMed ID: 22120630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
    Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
    Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.
    Robichaud J; Bayly CI; Black WC; Desmarais S; Léger S; Massé F; McKay DJ; Oballa RM; Pâquet J; Percival MD; Truchon JF; Wesolowski G; Crane SN
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3146-51. PubMed ID: 17408953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
    Kiat TS; Pippen R; Yusof R; Ibrahim H; Khalid N; Rahman NA
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3337-40. PubMed ID: 16621533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
    Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
    Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent nitrile-based inhibitors of cysteine cathepsins.
    Frizler M; Mertens MD; Gütschow M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7715-8. PubMed ID: 23122525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
    Johansson AC; Norberg-Spaak L; Roberg K
    Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.
    Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S
    Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine cathepsin proteases as pharmacological targets in cancer.
    Palermo C; Joyce JA
    Trends Pharmacol Sci; 2008 Jan; 29(1):22-8. PubMed ID: 18037508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells.
    Zhu DM; Uckun FM
    Clin Cancer Res; 2000 May; 6(5):2064-9. PubMed ID: 10815933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins.
    Roberts R
    Drug News Perspect; 2005 Dec; 18(10):605-14. PubMed ID: 16491162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
    Olson OC; Joyce JA
    Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Effects of Dietary Natural Products as Anti-Prostate Cancer Agents.
    Vue B; Zhang S; Chen QH
    Nat Prod Commun; 2015 Dec; 10(12):2179-88. PubMed ID: 26882694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents.
    Deaton DN; Kumar S
    Prog Med Chem; 2004; 42():245-375. PubMed ID: 15003723
    [No Abstract]   [Full Text] [Related]  

  • 16. Cathepsin K, osteoclastic resorption, and osteoporosis therapy.
    Zaidi M; Troen B; Moonga BS; Abe E
    J Bone Miner Res; 2001 Oct; 16(10):1747-9. PubMed ID: 11585336
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
    Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
    Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cathepsin K truly involved in bone resorption?
    Everts V
    J Bone Miner Res; 1998 Feb; 13(2):321-2. PubMed ID: 9495527
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary amides as selective inhibitors of cathepsin K.
    Léger S; Bayly CI; Black WC; Desmarais S; Falgueyret JP; Massé F; Percival MD; Truchon JF
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4328-32. PubMed ID: 17544269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.
    Li X; Chen D; Yin S; Meng Y; Yang H; Landis-Piwowar KR; Li Y; Sarkar FH; Reddy GP; Dou QP; Sheng S
    J Cell Physiol; 2007 Aug; 212(2):298-306. PubMed ID: 17458898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.